The findings of a new study support the development of Incyte‘s parsaclisib as a potential therapy for Sjögren’s…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
A new method for dividing people with primary Sjögren’s syndrome (pSS) into subgroups based on detailed molecular differences may…
Abnormalities in how mitochondria are “recycled” by cells could contribute to autoimmune diseases like Sjögren’s syndrome, a new study indicates. The…
Signaling molecules secreted by stem cells in teeth have anti-inflammatory properties that could be useful for the treatment of…
A newly established cellular model of the tear gland may be useful for studying Sjögren’s syndrome and other diseases…
Use of oral pilocarpine increased salivary flow in people with dry mouth due to primary Sjögren’s syndrome or other health…
Primary Sjögren’s syndrome (pSS) syndrome can be classified based on the extent of organ involvement, fatigue, and pain, with…
Interleukin-38, an immune signaling molecule known as IL-38, can reduce the inflammatory activity of a type of immune cells…
The arginase 1 protein appears to protect from dryness symptoms associated with Sjögren’s syndrome, potentially by lowering gland inflammation…
Wize Completes Phase 4 Study of LO2A Eye Drops for Sjögren’s; Results Expected Later This Year
A Phase 4 clinical trial evaluating Wize Pharma‘s LO2A eye drops as a treatment for dry eye…